Prognostic value of vascular endothelial growth factor in breast cancer.
about
Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stressThe mRNA expression of hTERT in human breast carcinomas correlates with VEGF expressionThe role of vascular endothelial growth factor a polymorphisms in breast cancerBevacizumab treatment for advanced breast cancerIdentification of prognostic factors in canine mammary malignant tumours: a multivariable survival studyEukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancerMitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expressionImmunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancerTumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genesPlatelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomasMicroenvironmental regulation of therapeutic response in cancerNovel Strategies to Improve the Endocrine Therapy of Breast Cancer.The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative OncoNerve growth factor promotes breast cancer angiogenesis by activating multiple pathways.Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast CancerMolecular diversity of VEGF-A as a regulator of its biological activity.Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis.Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularizationTrace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive x-ray fluorescenceLow ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors.Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancerIn vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer.Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy.Antiangiogenic therapies in early-stage breast cancer.Nitric Oxide Regulates Gene Expression in Cancers by Controlling Histone Posttranslational Modifications.Metronomic dosing of chemotherapy: applications in pediatric oncology.Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1.Emerging drugs to replace current leaders in first-line therapy for breast cancer.Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patientsPromise of multiphoton detection in discovery and diagnostic proteomics.Macrophages define the invasive microenvironment in breast cancer.Chemotherapy and molecular targeting therapy for recurrent cervical cancer
P2860
Q24797535-2B8FF281-2A0E-40D2-AE60-57D3DF248F4CQ24797652-602F90B1-A026-4A89-A505-D164D9A7D53EQ26851522-D9AAABCC-1621-40D3-AFFA-CF9D5DC367B7Q27027498-94995282-BB18-4839-9BD2-AC4682C34AB1Q31110389-A005E42A-CFDE-49B8-8AB0-9098F2A81F66Q33258854-815FFFDE-2556-40D6-B993-11596A4F9CA1Q33413005-8988D134-1E83-48DF-AADA-A42430F26B5DQ33428339-D67B4A2F-4068-4D78-B102-AA07C5BF6F9EQ33464944-FBB554EA-0092-4360-83C1-AC7E284ACF3CQ33510275-C05E87D8-748D-490C-82FC-908F1C44CC00Q33597254-E33DAD86-01E2-44FF-997B-49E93A737ABFQ33654609-31BE58D2-C8D3-4DF2-8738-D94E6218BAC1Q33727284-A8AB71BD-21DB-4DC2-BDDC-6345438EA3D4Q33739381-869EF3B9-0C6A-4464-9653-7D040ED16761Q33981022-6C6DA686-140C-487A-A1E2-DFC0A7C34CE3Q34080323-2795A6B1-301C-448A-A343-B33F0176244CQ34089123-B15C51F0-C208-41B8-81CC-6638A1E3F160Q34114041-BC51B86A-4FA2-405B-BD46-DBBCC74438C0Q34206305-2992429D-62E1-480A-A15F-D950BAA6D7F7Q34245766-0365EA6A-8748-4616-B095-B7784BC103D4Q34429766-B66DDCE0-96E0-44E5-A2C5-DB3055006BC1Q34440220-22169DD8-1928-485B-A80E-CAECE00D697BQ34612480-BC3E0192-8995-4636-9CB8-9A6EBFE20549Q34708511-956622F2-6A95-470D-AB35-EE821509C5CCQ34991214-BA721E8C-086F-4473-9DB1-E4243965C807Q35098081-9541F680-ABBB-4BCA-A3D1-D6127DA8526DQ35221417-06EBD85A-E92A-43E9-B3A8-9F92EB463EE7Q35748149-39B22751-7749-4E01-AD48-3167B7FB2B69Q36244136-A6FE0DCD-7146-40DF-ABC3-CEC62D2438EDQ36318210-7BCA537B-CBEC-4AB3-ABEB-36968CD4F16BQ36378173-35859A69-EB3A-4ED3-B43B-26FE34BF1814Q36508092-DDC18F15-77C7-42CD-8A2A-54821AC9A9F3Q36523877-98F83B4D-94B8-4C47-9E3F-9C201EAE6906Q36580598-2F9D4CF3-53E2-45B9-A36F-C9315809F2DFQ36611325-4CF59145-7B02-440A-8EC8-AD5D8CB7293FQ36616962-3FD1FF98-ED47-49A3-9AB8-0D677723B7ACQ36649036-BA5720FC-B1B4-48BD-BE94-0F278C76CACCQ36787218-EC35C9FC-39F8-45F3-B390-5D0EC3D304EFQ36838542-75E82A7E-8F93-48DA-84C1-1CA79C1244E5Q36897266-2445ADF5-1740-42D7-A771-AD55A2DA929D
P2860
Prognostic value of vascular endothelial growth factor in breast cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prognostic value of vascular endothelial growth factor in breast cancer.
@ast
Prognostic value of vascular endothelial growth factor in breast cancer.
@en
type
label
Prognostic value of vascular endothelial growth factor in breast cancer.
@ast
Prognostic value of vascular endothelial growth factor in breast cancer.
@en
prefLabel
Prognostic value of vascular endothelial growth factor in breast cancer.
@ast
Prognostic value of vascular endothelial growth factor in breast cancer.
@en
P1433
P1476
Prognostic value of vascular endothelial growth factor in breast cancer.
@en
P2093
Gasparini G
P356
10.1634/THEONCOLOGIST.5-SUPPL_1-37
P478
P577
2000-01-01T00:00:00Z